Skip to main content

Day: July 22, 2025

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors

– Mr. Schoeneck is a seasoned industry executive and director with deep expertise in development and commercialization of breakthrough products and guiding companies through significant transformation and growth – SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced the expansion of the size of its Board of Directors from six to seven directors and the appointment of Jim Schoeneck as a director effective today. “We are pleased to welcome Jim to our Board of Directors,” said Kleanthis G. Xanthopoulos, Chairman of the Board of Directors. “His deep expertise in drug development and commercialization will make him an...

Continue reading

LPL Financial Welcomes Gallagher Wealth Management

SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Kevin Gallagher, AIF®, of Gallagher Wealth Management has joined LPL Financial’s broker-dealer, Registered Investment Advisor (RIA) and custodial platforms. He reported serving approximately $180 million in advisory, brokerage and retirement plan assets* and joins LPL from Lincoln Investment. Located north of Washington D.C. in Brookeville, Md., Gallagher started in the wealth management industry as a floor trader in 1997 following a career in the U.S. Marines. Now, with nearly two decades of financial industry experience, Gallagher has established a reputation as an advisor who takes an individualized approach to wealth management, offering clients — who are mostly former or current federal employees or members of the military — a personalized and...

Continue reading

Reborn Coffee Expands into Georgia and Armenia Through Licensing Agreement with Arjomand Group and IG International

Strategic Partnership Strengthens Reborn’s Presence in the Caucasus Region and Aligns with Growing Regional Business Confidence BREA, Calif., July 22, 2025 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee market, today announced it has signed a strategic licensing agreement with The Arjomand Group and IG International, officially marking Reborn’s expansion into the Republics of Georgia and Armenia. The agreement grants IG International exclusive rights to develop and operate Reborn Coffee-branded locations across both Georgia and Armenia, under the framework of a regional licensing partnership facilitated by The Arjomand Group. The move reflects Reborn’s ongoing international expansion strategy and positions the brand at the center of two emerging markets with growing consumer demand and increased...

Continue reading

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit

Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 IRVINE, Calif., July 22, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will host its inaugural Lap-Band® Surgeon Summit, taking place August 1-3, 2025 in Nashville, Tennessee. Dr. Christine Ren-Fielding, M.D., Professor of Surgery at NYU Grossman School of Medicine, Director of the NYU Langone Weight Management Program, and Chief of the Division of Bariatric Surgeons, will direct the Summit, where she and other faculty will present to over 20 leading Lap-Band® surgeons. “Our inaugural Lap-Band® Surgeon Summit brings together leading bariatric surgeons and underscores our continued commitment to growing the Lap-Band® franchise,”...

Continue reading

374Water Delivers AS6 System to Detroit, Michigan for DoD ESTCP/DIU Project

Installation and Commissioning Activities Commenced with Treatment of Six PFAS-Impacted Waste Streams to Begin in August ESTCP will Demonstrate Treatment Options for DoD Installations Impacted by Hazardous Chemicals Found in Firefighting Foams, Industrial Processes, and Contaminated Water Sources DURHAM, N.C., July 22, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced the successful mobilization and delivery of its AirSCWO 6 System for a series of commercial-scale demonstrations at Clean Earth’s Detroit, MI facility as part of a previously announced Department of Defense (“DoD”) project. In February, 374Water announced its participation in a highly anticipated...

Continue reading

VERSES® Announces Corporate Update Webinar and Ticker Symbol Change

Stock ticker symbol reverts back to VRSSF on OTCQB VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, announces a corporate update webinar for investors. On Tuesday, July 29th at 9:30 AM Pacific Time, VERSES Co-Founder and CEO Gabriel René and President James Hendrickson will host a live webinar and Company update that will provide the latest developments on Genius™, VERSES’ next generation platform for intelligent software agents. This webinar will also provide a discussion of the Company’s business strategy, developments to date, and upcoming roadmap. To register for the webinar anytime up to and during the event use this link: https://event.webinarjam.com/register/13/pv6q8cy Additionally,...

Continue reading

Akari Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Video webcast now available on-demand BOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced Abizer Gaslightwala, Director, President and Chief Executive Officer of Akari, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference. As part of the event, Mr. Gaslightwala dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development. The on-demand video webcast is now available on virtualinvestorco.com as well as the Presentations page in the Investors section of the Company’s website (akaritx.com). About...

Continue reading

Senti Biosciences Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D., Ph.D., Senti Bio’s Co-Founder and Chief Executive Officer of Senti, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference. As part of the event, Dr. Lu dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development. The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page under the Investors section of the Company’s...

Continue reading

Outlook Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that Bob Jahr, newly appointed Chief Executive Officer, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference. As part of the event, Mr. Jahr dove deeper into what brought him to Outlook Therapeutics, how he got to where he is today and provided insight into why he is excited about the future for Outlook Therapeutics. The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page under the Investors section of the Company’s website (outlooktherapeutics.com). About Outlook Therapeutics, Inc. Outlook...

Continue reading

GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced Marc Hertz, PhD, President, Chief Executive Officer and Director of GRI BIO, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference. As part of the event, Dr. Hertz dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development. The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page under the Investors section of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.